MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

4595 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MIZUHO MEDY Co., Ltd., based in Tosu, Saga, Japan, specializes in in vitro diagnostics, offering a comprehensive range of innovative products. The company is renowned for its advanced nucleic acid amplification tests and rapid immunoassays catering to clinical, research, and agricultural applications. Notable offerings include the Smart Gene® series and the Quick Chaser line, which addresses various pathogens, including SARS-CoV-2 and RSV. Committed to quality, MIZUHO MEDY has achieved ISO 13485 certification for its operations, ensuring adherence to stringent quality management standards. With a focus on technological advancement, the company actively participates in international exhibitions, showcasing its commitment to healthcare innovation and improving diagnostic solutions.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for MIZUHO MEDY CO.,LTD.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-02 06:17
Regulatory News Service
臨時報告書
Japanese 25.9 KB
2025-03-31 03:44
Regulatory News Service
内部統制報告書-第48期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-31 03:41
Regulatory News Service
確認書
Japanese 8.7 KB
2025-03-31 03:37
Annual Report
有価証券報告書-第48期(2024/01/01-2024/12/31)
Japanese 931.6 KB
2024-08-09 06:11
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-09 06:09
Interim Report
半期報告書-第48期(2024/01/01-2024/12/31)
Japanese 209.8 KB
2024-05-10 06:07
Regulatory News Service
確認書
Japanese 8.7 KB
2024-05-10 06:06
Quarterly Report
四半期報告書-第48期第1四半期(2024/01/01-2024/03/31)
Japanese 169.5 KB
2024-04-01 09:48
Regulatory News Service
臨時報告書
Japanese 21.6 KB
2024-03-29 02:02
Regulatory News Service
内部統制報告書-第47期(2023/01/01-2023/12/31)
Japanese 22.5 KB
2024-03-29 01:59
Regulatory News Service
確認書
Japanese 8.7 KB
2024-03-29 01:56
Annual Report
有価証券報告書-第47期(2023/01/01-2023/12/31)
Japanese 967.0 KB
2023-11-10 05:09
Regulatory News Service
確認書
Japanese 8.7 KB
2023-11-10 05:07
Quarterly Report
四半期報告書-第47期第3四半期(2023/07/01-2023/09/30)
Japanese 171.4 KB
2023-08-10 06:09
Regulatory News Service
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all MIZUHO MEDY CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MIZUHO MEDY CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK